This educational program aims to update practitioners on advances in the diagnosis and treatment of Parkinson’s disease, multiple sclerosis, stroke, dementia and related disorders. We will discuss evidence-based management, improvements in therapeutic rehabilitation, and updates on therapeutic theory and practice.
The provider should avoid betraying an emotional response
It important to “push past” the patients’ emotional expressions to focus on the facts of the case
Receiving a negative diagnosis is psychologically harmful to the patient
Medical terminology should be avoided unless necessary to promote understanding
The provider should get to the point (the diagnosis and plan) as quickly as possible
Depression
Fatigue
Tremor
Apathy
Rate this question:
Sialorrhea
Dystonia
Spasticity
Spasmodic dysphonia
Motor Neuron Disease
Rate this question:
3 hours
4.5 hours
6 hours
7 hours
12 hours
Rate this question:
Platelet transfusion
Acute SBP lowering < 140
Craniotomy
IV tPA
N/A
Rate this question:
Patients are generally younger than 65 years
Atypical patients make up about 40% of AD cases
Hippocampal atrophy may be absent
Cortical atrophy may be more focal
Rate this question:
Patients with persistent or progressive unexplained MCI
To determine dementia severity
Patients with progressive dementia and atypically early age of onset (65 years or less in age)
Asymptomatic individuals
All of the above
A and C
B and D
Rate this question:
Visuospatial
Executive
Processing Speed
Memory
Rate this question:
Visuospatial
Executive
Processing Speed
Memory
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
Weakness
Pain
Fatigue
Cognitive impairment
Rate this question:
SpeechVive
LSVT
Expiratory Muscle Trainers
Buck Rogers Walkie Talkies
Rate this question:
Paper and pencil
Speech generating Device
Sign Language
Smartphone
Rate this question:
Outer plexiform layer
Photoreceptor inner segment
Inner nuclear layer
Ganglion cell + inner plexiform layer
Retinal pigment epithelium
Rate this question:
Retained motor parkinsonism as the core feature (bradykinesia plus rest tremor or rigidity)
Postural instability
Increasing recognition to non-motor manifestations
Rate this question:
Daclizumab
Alemtuzumab
Ocrelizumab
Siponimod
Ofatumumab
Rate this question:
Quiz Review Timeline (Updated): Mar 14, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
Wait!
Here's an interesting quiz for you.